Fri, July 19, 2024
[ 12:00 AM ] - WOPRAI
Mon, April 22, 2024
[ 12:00 AM ] - WOPRAI
Wed, February 21, 2024
[ 12:00 AM ] - WOPRAI
Mon, October 23, 2023
[ 12:00 AM ] - WOPRAI
Fri, October 20, 2023
[ 12:00 AM ] - WOPRAI
Wed, July 26, 2023
[ 12:00 AM ] - WOPRAI
Mon, June 12, 2023
[ 12:00 AM ] - WOPRAI
Mon, May 8, 2023
[ 12:00 AM ] - WOPRAI
Fri, April 28, 2023
[ 12:00 AM ] - WOPRAI
Thu, April 27, 2023
[ 12:00 AM ] - WOPRAI
Fri, March 31, 2023
[ 12:00 AM ] - WOPRAI
Tue, February 28, 2023
[ 12:00 AM ] - WOPRAI
Wed, February 8, 2023
[ 12:00 AM ] - WOPRAI
Tue, December 13, 2022
[ 12:00 AM ] - WOPRAI
Thu, October 27, 2022
[ 12:00 AM ] - WOPRAI
Tue, August 30, 2022
[ 12:00 AM ] - WOPRAI
Thu, April 28, 2022
[ 12:00 AM ] - WOPRAI
Fri, November 19, 2021
[ 12:00 AM ] - WOPRAI
Tue, November 16, 2021
[ 12:00 AM ] - WOPRAI
Wed, September 15, 2021
[ 12:00 AM ] - WOPRAI
Thu, August 19, 2021
[ 12:00 AM ] - WOPRAI
Mon, June 15, 2020
[ 12:00 AM ] - WOPRAI
Wed, December 11, 2019
Daniel Grosslight Maintained (CAH) at Hold with Decreased Target to $107 on, Jul 19th, 2024
Daniel Grosslight of Citigroup, Maintained "Cardinal Health, Inc." (CAH) at Hold with Decreased Target from $115 to $107 on, Jul 19th, 2024.
Daniel has made no other calls on CAH in the last 4 months.
There are 5 other peers that have a rating on CAH. Out of the 5 peers that are also analyzing CAH, 2 agree with Daniel's Rating of Hold. Following are those relevant analyst calls for the last 4 months
- Elizabeth Anderson of "Evercore ISI Group" Maintained at Hold with Decreased Target to $105 on, Tuesday, July 9th, 2024
- George Hill of "Deutsche Bank" Maintained at Hold with Decreased Target to $110 on, Monday, May 6th, 2024
These are the ratings of the 3 analyists that currently disagree with Daniel
- Eric Coldwell of "Baird" Maintained at Buy with Increased Target to $130 on, Tuesday, July 9th, 2024
- David Toung of "Argus Research" Maintained at Strong Buy with Decreased Target to $115 on, Wednesday, May 15th, 2024
- Stephen Baxter of "Wells Fargo" Maintained at Sell with Decreased Target to $94 on, Monday, April 29th, 2024
Contributing Sources